Alliance Pharmaceuticals
Alliance Pharmaceuticals is a leading international consumer healthcare business. From its origins in the UK over 20 years ago, Alliance has grown to market its products in over 100 countries worldwide, employing around 285 people based in locations across Europe, North America and the Asia Pacific region.
For more than 20 years we have worked with Alliance to protect and enforce its trade marks, such as MACUSHIELD, KELO-COTE, VAMOUSSE, LYPSYL, ANBESOL and HYDROMOL, in countries all over the world.
Working closely with Alliance’s in-house legal team, our role is diverse and constantly evolving. We hold strategy meetings twice a month, have provided training on intellectual property to brand managers and marketing teams, and partner Rebecca Anderson-Smith spent some time in-house during a secondment. Our long-standing relationship means we are trusted to ease the load of the legal team by working directly with other individuals within the business as needed.
Prior to entry into new markets, we devise international trade mark searching and filing strategies, balancing the desire to obtain the broadest possible protection, against associated risks and any budgetary constraints.
We coordinate the results of searches from attorneys in countries all over the world, cutting through any legal jargon, in order to present clear and honest opinions on the legal position, alongside creative and commercially focused solutions.
We make use of a number of systems for obtaining trade marks, including national trade mark applications and the Madrid Protocol system, always with an eye to the goals of the business for each particular brand and jurisdiction. We never take a ‘one size fits all’ approach.
We also assist Alliance with enforcement of its trade marks all over the world, working with a large network of trusted contacts in other jurisdictions. This is not only through the filing of trade mark oppositions and cancellations, sending letters to potential infringers, and bringing actions before the national courts, but also through international Customs enforcement work.
In every situation, we carefully consider with Alliance what a successful outcome looks like. This will depend on the brand, market and nature of any potential conflict. We regularly negotiate commercial solutions, recognising that the legal enforcement option available is not always the best choice. We always act with a view to achieving their ultimate business goal, protecting their position in the market and the reputation of their brands, which in the pharmaceutical and consumer healthcare field is absolutely vital.
International Protection Strategy
Our client has been researching and developing innovative new products in the pharmaceutical space but does not yet have regulatory approval. We have devised robust international filing strategies to successfully protect and, importantly, maintain protection for their house mark and product names, navigating the challenges of requirements for genuine use of a trade mark in commerce in many jurisdictions.
Enforcement of Trade Marks
We assisted our client with UK trade mark infringement proceedings and connected trade mark oppositions. A key issue on which our expertise was sought was the extent to which there can be genuine use and/or justifiable non-use of a UK trade mark where clinical trials are still underway.
Clearance Project
Our client requested our assistance in assessing the availability for use and registration of a number of possible trade marks for their veterinary products. We began by conducting identical trade mark searches for six possible candidate names on an international basis. The preferred name was then put forward for more comprehensive searching across key jurisdictions. When issues were identified, we conducted further searches for an alternative name. We also supported the client with trade mark applications in various jurisdictions.